Skip to main content

Table 3 Outcomes of the patients enrolled

From: Comparison of extracorporeal membrane oxygenation outcome for influenza-associated acute respiratory failure in Japan between 2009 and 2016

Year

2009

2016

p value

Ventilator days before ECMO (days)

5.0 (1.0–7.0)

1.0 (1.0–2.8)

0.11

Total ventilator days (days)

19 (9–25)

27 (14–38)

0.24

Ventilator-free days (days)

1.5 (0–10.5)

7.5 (4–27)

0.12

Length of ECMO therapy (days)

8.5 (4.5–10.0)

10.0 (8.3–32.5)

0.08

Number of circuits used

2.0 (1.3–3.0)

1.0 (1.0–2.0)

0.14

Duration of each circuit (days)

4.0 (3.3–4.9)

8.5 (6.5–14.9)

0.0001

Number of patients (per institute)

1.0 (1.0–1.0)

1.0 (1.0–1.8)

0.42

Length of ICU stay (days)

17 (9–26)

29 (20–41)

0.038

Length of ICU stay in survived patients (days)

24 (17–26)

24 (20–38)

0.57

Length of hospital stay (days)

25 (12–53)

41 (27–65)

0.14

Length of hospital stay in survived patients (days)

69 (40–77)

42 (23–70)

0.38

Days alive (days)

25 (14–46)

43 (37–73)

0.073

Overall survival rate

5 (36)

11 (79)

0.054

In-hospital survival rate

5 (36)

11 (79)

0.054

60-day survival rate

5 (36)

12 (86)

0.018

  1. Data are expressed as median (interquartile) or number (%)
  2. ECMO extracorporeal membrane oxygenation, ICU intensive care unit, NA not available